In Scientific Publishing, Sharing Is Caring
The Saga for Open-Access Research Continues
Cell-Free DNA Drives Liquid Biopsy Testing
Researchers Are Diligently Finding Ways to Use Scraps of cfDNA in Clinically Relevant Ways
Raising the Bar of Cell Line Authentication
Researchers May Be Slow to Implement Protocols Unless They Are Pressured
Optical DNA Mapping Identifies Disease-Causing Mutations
Bionano Saphyr Spots Inversions and Large Deletions in Genomes
For full access to this article login to GEN Select now.
Road to Antibiotic Approval Made Clearer
Regulatory Hurdles Are Higher, but a New Well-Defined Path Means We Know How High to Jump
- Antibiotic development has become a challenging therapeutic area. Shifting and evolving regulatory guidelines have made design of clinical trials difficult and the prospect for marketing approval fairly low. In addition, the short-term treatment regimens have made the sector relatively unattractive from a return on investment perspective, particularly for antibiotics ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.